COTA Descends on NYC for CAMP COTA
After two years, COTA was back together in NYC for an in-person all-hands meeting. As much as we have learned to adapt to the world of remote work, there is no substitute for the connection, collaboration, and energy that comes from physically being in the same space.
From Regulatory to RWD: A Journey to Improve Cancer Care with COTA
Working with the FDA and now COTA Laura describes why real-world data is an integral part of today’s patient care.
COTA Promotes Paige Whitney to Senior Vice President to Expand the Use of Real-World Data in Life Sciences
Paige Whitney will join the executive leadership team as Senior Vice President of Life Sciences. Paige is responsible for growing the company’s industry partnerships and strengthening COTA’s position as a leading provider of oncology RWD.
The Roadmap for Making Clinical Trials More Diverse and Representative
Diversity in clinical trials is a change that needs to be made in order to make all efforts more efficient and develop a better ending result for patients. Karla Feghali and Laura Fernandes detail why this is so necessary moving forwards.
COTA Collaborates with University of Chicago Medicine and UT Southwestern on Research To Be Presented at the American Society for Hematology’s Annual Meeting & Exposition
Four abstracts will be showcased at the American Society for Hematology’s (ASH) Annual Meeting & Exposition from December 11–14, 2021, in Atlanta, Georgia. COTA has the most comprehensive hematology oncology real-world data that is curated under the close guidance of leading oncologists and hematology specialists.
Rewriting the Oncology Patient’s Journey with Real-World Data
Life science stakeholders are committed to making the path to positive outcomes less frightening and convoluted for patients. With breakthrough treatments and innovative therapies targeted to the toughest of cancers, the industry has made significant progress with guiding patients toward longer, healthier lives.
With New FDA Guidance on Real-World Data, What’s the Next Step for Clinical Trials?
In September 2021, the FDA published new draft guidance as part of its ongoing efforts to explore the use of real-world data (RWD) and real-world evidence (RWE) within its regulatory decision-making process.
COTA, Inc. announces Ritu Bahal has joined the company to serve as Chief Financial Officer
As CFO, Ritu will oversee all aspects of COTA’s financial strategy as it enters the next phase of growth. She will support COTA’s overall mission of bringing clarity to cancer care by devising and implementing sound financial strategies to maximize revenue growth and operational efficiencies, increasing financial transparency and engaging with investors.
Growing Our Team During the Pandemic
Thanks to the pandemic, remote work is more collaborative, but hiring and onboarding new employees has its share of challenges. Thankfully we were able to pivot and COTA is proud of the process we’re using to recruit new employees.
COTA to Accelerate Life Sciences Impact With Addition of Christine Kawiecki from IBM Watson Health
With more than 25 years of healthcare experience, Christine Kawiecki joins the COTA, Inc. team to support business growth as life sciences companies are increasingly turning to real-world data to accelerate drug development in a post-pandemic world.
